BridgeMD
Tests treatment safety and results for Irritable Bowel Syndrome
Official title Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
ClinicalTrials.gov ID: NCT05740319
What this study is testing
- What it's testing
- Participants will be given FMT through oral capsules or nasojejunal tube once a month. After three-time treatment, participants were followed up for three months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Patients who fulfilled the Rome IV criteria for the diagnosis of IBS, aged 18-70 years;
- Patients who have experienced failure of at least 3 conventional therapies for IBS;
- Absence of red flags such as weight loss, hematochezia;
You likely can't join if
- Pregnant, planning pregnancy or lactating;
- Psychiatric disorder or unable to cooperate with treatment and follow-up visit;
- Immunodeficiency or treatment with immune-modulating medication;
- Use of probiotics within the previous 3 months or treatment with antibiotics within 1 month prior to study entry;
- Having undergone any abdominal surgery, with the exception of appendectomy, cholecystectomy, caesarean section and hysterectomy;
- Presence of uncontrolled diabetes, hypertension, thyroid disease or other systemic disease;
See the full eligibility criteria
- Patients who fulfilled the Rome IV criteria for the diagnosis of IBS, aged 18-70 years;
- Patients who have experienced failure of at least 3 conventional therapies for IBS;
- Absence of red flags such as weight loss, hematochezia;
- Pregnant, planning pregnancy or lactating;
- Psychiatric disorder or unable to cooperate with treatment and follow-up visit;
- Immunodeficiency or treatment with immune-modulating medication;
- Use of probiotics within the previous 3 months or treatment with antibiotics within 1 month prior to study entry;
- Having undergone any abdominal surgery, with the exception of appendectomy, cholecystectomy, caesarean section and hysterectomy;
- Presence of uncontrolled diabetes, hypertension, thyroid disease or other systemic disease;
- Presence of severe diseases related to heart, brain, kidney and lung or concomitant malignancies;
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.